Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Age-dependent effects of methamphetamine on VMAT-2.
Rau KS, Truong JG, Wilkins DG, Fleckenstein AE, Hanson GR. Rau KS, et al. Among authors: wilkins dg. Ann N Y Acad Sci. 2006 Aug;1074:154-9. doi: 10.1196/annals.1369.015. Ann N Y Acad Sci. 2006. PMID: 17105913
Bupropion increases striatal vesicular monoamine transport.
Rau KS, Birdsall E, Hanson JE, Johnson-Davis KL, Carroll FI, Wilkins DG, Gibb JW, Hanson GR, Fleckenstein AE. Rau KS, et al. Among authors: wilkins dg. Neuropharmacology. 2005 Nov;49(6):820-30. doi: 10.1016/j.neuropharm.2005.05.004. Epub 2005 Jul 7. Neuropharmacology. 2005. PMID: 16005476
Mechanisms underlying methamphetamine-induced dopamine transporter complex formation.
Hadlock GC, Baucum AJ 2nd, King JL, Horner KA, Cook GA, Gibb JW, Wilkins DG, Hanson GR, Fleckenstein AE. Hadlock GC, et al. Among authors: wilkins dg. J Pharmacol Exp Ther. 2009 Apr;329(1):169-74. doi: 10.1124/jpet.108.145631. Epub 2009 Jan 13. J Pharmacol Exp Ther. 2009. PMID: 19141713 Free PMC article.
Methamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high-dose methamphetamine administration.
McFadden LM, Hoonakker AJ, Vieira-Brock PL, Stout KA, Sawada NM, Ellis JD, Allen SC, Walters ET, Nielsen SM, Gibb JW, Alburges ME, Wilkins DG, Hanson GR, Fleckenstein AE. McFadden LM, et al. Among authors: wilkins dg. Synapse. 2011 Aug;65(8):771-7. doi: 10.1002/syn.20902. Epub 2011 Mar 21. Synapse. 2011. PMID: 21190217 Free PMC article.
4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse.
Hadlock GC, Webb KM, McFadden LM, Chu PW, Ellis JD, Allen SC, Andrenyak DM, Vieira-Brock PL, German CL, Conrad KM, Hoonakker AJ, Gibb JW, Wilkins DG, Hanson GR, Fleckenstein AE. Hadlock GC, et al. Among authors: wilkins dg. J Pharmacol Exp Ther. 2011 Nov;339(2):530-6. doi: 10.1124/jpet.111.184119. Epub 2011 Aug 2. J Pharmacol Exp Ther. 2011. PMID: 21810934 Free PMC article.
Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure.
McFadden LM, Hadlock GC, Allen SC, Vieira-Brock PL, Stout KA, Ellis JD, Hoonakker AJ, Andrenyak DM, Nielsen SM, Wilkins DG, Hanson GR, Fleckenstein AE. McFadden LM, et al. Among authors: wilkins dg. J Pharmacol Exp Ther. 2012 Feb;340(2):295-303. doi: 10.1124/jpet.111.188433. Epub 2011 Oct 27. J Pharmacol Exp Ther. 2012. PMID: 22034657 Free PMC article.
127 results